June #60 : Next Up… - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Friend of Tinky

Brothers' Keeper

The New AIDS Look

Publisher's Letter

Mailbox

Death Of A Diva

Israel’s Madonna

Catching Up With...

Big Prison Break

NEG/POS

The Maine Event

Say What?

Shout Out

Everybody’s Business

Bookmark This

Family Portrait, With Fidel

On Making A Hard Sell

The Riddle Of Limerick

Winter White

Stay On Course

Shattered!

Helping Hands

Smoke Alarm

Mixed Messages

PEP Rally

Herb Of The Month

Traveling The Light

Comfort Zone

E-Mail Bonding

What Big Enzymes You Have

Next Up…

Hot Off the Stress

6.30.89: Art Throb

Have HIV, Will Travel



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

June 2000

Next Up…

by Tim Horn

The lowdown of what’s in the pipeline

Generic Name: Tenofovir
Brand Name: To be announced
Company: Gilead Sciences
For: HIV
Class: Nucleotide analogue
Status: Phase III trials under way
Standard Treatment: Other HAART meds
Notes: Test-tube studies suggest it may be potent against 3TC-resistant strains of HIV and several other viruses. This once-daily drug looks less likely than adefovir (Gilead’s first nucleotide) to damage the kidneys, but it can induce headaches,
nausea and diarrhea.
From the gut of PWA Stephen Gendin: “After the debacle with adefovir (rejected by the FDA due to toxicity), Gilead has a lot riding on this one. Its early expanded access program is welcome news.”


Generic Name: Calanolide-A
Brand Name: To be announced
Company: Sarawak MediChem
For: HIV
Class: NNTRI
Status: Phase II trials underway
Standard Treatment: Other HAART meds
Notes: An NNRTI—derived from a rain-forest tree—that has researchers confused: Small human studies show that it dramatically reduces viral load after a month, but has no effect for the first two weeks. No HIVers developed resistance to the drug, even as monotherapy.
From the gut of PWA Stephen Gendin: “With data this weird, I wouldn’t pin hope on this drug until more trials are done. And there’s no such thing as a drug that HIV can’t become resistant to.”

Generic Name: Valganciclovir
Brand Name: To be announced
Company: Roche Laboratories
For: CMV retinitis
Class: Antiviral
Status: Phase II trials under way
Standard Treatment: IV ganciclovir, foscarnet and cidofovir
Notes: Finally, an oral drug being developed to treat this sight-stealing virus. A 160-person trial found a longer time to retinitis relapse with valganciclovir (198 days) than with IV ganciclovir (120 days); both drugs can cause severe neutropenia (a white blood cell deficiency).
From the gut of PWA Stephen Gendin: “With CMV rates much lower since protease inhibitors came along, it’s nice to see this company is still working on improving CMV treatments.”

Generic Name: N/A                           
Brand Name: SB Normal Stool Formula
Company: Shaman Botanicals
For: Diarrhea
Class: Antidiarrheal
Status: On market as supplement, www.shamanbotanicals.com
Standard Treatment: Imodium-AD, Lomotil, Kaopectate, other meds
Notes: Contains a rain-forest tree-sap extract used for centuries to fight diarrhea. In trials of 500 PWAs, it improved diarrhea by reducing water flow into intestines. Many anecdotes of effectiveness against HIV med–induced runs. So far, no reported side effects.
From the gut of PWA Stephen Gendin: “It’s expensive, but does seem to work very well and is sometimes reimbursable. Definitely worth trying for a couple of weeks if you’ve got unresponsive diarrhea.”



[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    Sin_Grinder
    Reno
    Nevada


    jimmy807
    San Antonio
    Texas


    kmfdm221
    Arcata
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.